Search research articles
Contact Us
Filters
Showing results (11-20 of 70) with videos related to
Page
of 7
Sort By:
Cardiovascular Research
|
February 1, 1994
Endothelial protection by converting enzyme inhibitors
G Wiemer, B A Schölkens, W Linz
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
March 1, 1974
Mitochondria from brown adipose tissue: influence of albumin, guanine nucleotides and of substrate level phosphorylation on the internal adenine nucleotide pattern
J Rafael, G Wiemer, H J Hohorst
The American Journal of Cardiology
|
August 4, 1997
Beneficial effects of bradykinin on myocardial energy metabolism and infarct size
W Linz, G Wiemer, B A Schölkens
Hypertension (Dallas, Tex. : 1979)
|
December 26, 2001
Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarction
G Wiemer, G Itter, T Malinski, et al.
European Journal of Pharmacology
|
December 15, 1994
The bradykinin B2 receptor antagonist WIN 64338 inhibits the effect of des-Arg9-bradykinin in endothelial cells
K J Wirth, B A Schölkens, G Wiemer
Polish Journal of Pharmacology and Pharmacy
|
March 1, 1984
Increase of Bmax-values of beta-adrenoceptor sites after chronic treatment with reserpine?
A Wellstein, B Jablonka, G Wiemer, et al.
Agents and Actions. Supplements
|
January 1, 1992
Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin
G Wiemer, B A Schölkens, R H Becker
Experientia
|
August 15, 1979
Inversal relationship between basal adenylcyclase activity and maximal degree of stimulation in membranes of red blood cells from rats
G Wiemer, G Kaiser, J Dietz, et al.
Agents and Actions. Supplements
|
January 1, 1992
DesArg10[Hoe 140] is a potent B1 bradykinin antagonist
K J Wirth, G Wiemer, B A Schölkens
Blut
|
December 15, 1978
Direct characterization of beta-adrenoceptors in membranes of immature red blood cells from rats
G Kaiser, G Wiemer, J Dietz, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 70) with videos related to
Sort By:
Page
of 7
Cardiovascular Research
|
February 1, 1994
Endothelial protection by converting enzyme inhibitors
G Wiemer, B A Schölkens, W Linz
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
March 1, 1974
Mitochondria from brown adipose tissue: influence of albumin, guanine nucleotides and of substrate level phosphorylation on the internal adenine nucleotide pattern
J Rafael, G Wiemer, H J Hohorst
The American Journal of Cardiology
|
August 4, 1997
Beneficial effects of bradykinin on myocardial energy metabolism and infarct size
W Linz, G Wiemer, B A Schölkens
Hypertension (Dallas, Tex. : 1979)
|
December 26, 2001
Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarction
G Wiemer, G Itter, T Malinski, et al.
European Journal of Pharmacology
|
December 15, 1994
The bradykinin B2 receptor antagonist WIN 64338 inhibits the effect of des-Arg9-bradykinin in endothelial cells
K J Wirth, B A Schölkens, G Wiemer
Polish Journal of Pharmacology and Pharmacy
|
March 1, 1984
Increase of Bmax-values of beta-adrenoceptor sites after chronic treatment with reserpine?
A Wellstein, B Jablonka, G Wiemer, et al.
Agents and Actions. Supplements
|
January 1, 1992
Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin
G Wiemer, B A Schölkens, R H Becker
Experientia
|
August 15, 1979
Inversal relationship between basal adenylcyclase activity and maximal degree of stimulation in membranes of red blood cells from rats
G Wiemer, G Kaiser, J Dietz, et al.
Agents and Actions. Supplements
|
January 1, 1992
DesArg10[Hoe 140] is a potent B1 bradykinin antagonist
K J Wirth, G Wiemer, B A Schölkens
Blut
|
December 15, 1978
Direct characterization of beta-adrenoceptors in membranes of immature red blood cells from rats
G Kaiser, G Wiemer, J Dietz, et al.
Page
of 7